Summary
                        
        
                            Includes methods for the implementation of interim analyses randomisation patient allocation and blinding safety monitoring and pharmacovigilance data management governance sponsorship site management selection of third party vendors clinical supplies and manufacturing issues around introduction and removal of treatments protocol deviations trial longevity and intervention selection
                    
    
        
                                 
                    More information & hyperlinks
                        
         
                             
                             
                            